1,8-Diazabicyclo(5.4.0)undec-7-ene → HCID 19006026, compound
Reaction equation
[CH:1]1([N:4]2[C:13]3[C:8](=[CH:9][C:10]([F:16])=[C:11](F)[C:12]=3[F:14])[C:7](=[O:17])[C:6]([C:18]([OH:20])=[O:19])=[CH:5]2)[CH2:3][CH2:2]1.[N:21]1([CH:26]2[CH2:31][CH2:30][CH2:29][N:28](Cl)[CH2:27]2)[CH:25]=[CH:24][N:23]=[N:22]1.C1CCN2C(=NCCC2)CC1>C(#N)C>[CH:1]1([N:4]2[C:13]3[C:8](=[CH:9][C:10]([F:16])=[C:11]([N:28]4[CH2:29][CH2:30][CH2:31][CH:26]([N:21]5[CH:25]=[CH:24][N:23]=[N:22]5)[CH2:27]4)[C:12]=3[F:14])[C:7](=[O:17])[C:6]([C:18]([OH:20])=[O:19])=[CH:5]2)[CH2:3][CH2:2]1Participants
5
Procedure
To a suspension of 1-cyclopropyl-6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid (50 mg, 0.18 mmol) and 3-(1,2,3-triazol-1-yl)piperidine-1-yl hydrochloride (83 mg, 0.44 mmol) in 3 ml of acetonitrile was added 67 mg (0.44 mmol) of DBU. The solution was heated at reflux under nitrogen for 16 hrs. The suspension was cooled and the solid collected, washed with water, dried to yield 50 mg of the title product, m.p. 239°-240° C. 1H NMR (TFA) δ: 9.35 (s, 1H), 8.61 (s, 1H), 8.51 (s, 1H), 8.16 (d, J=10.6Hz, 1H), 5.45-5.15 (m, 1H), 4.7-3.55 (m, 5H), 2.85-2.05 (m, 4H), 1.8-1.3 (m, 4H).
Workup
- temperatureThe solution was heated
- temperatureat reflux under nitrogen for 16 hrs
- temperatureThe suspension was cooled
- customthe solid collected
- washwashed with water
- customdried
Sources & evidence
- ORD record
- ord-7a41607280464ae2ba2e942313447f6e
- Source dataset
- uspto-grants-1994_08
- Patent number
- US05342846
Reaction notes
Loading…